Comparison of the Effectiveness of Two Different Surgical Therapeutic Protocols of Peri-implantitis

Last updated: April 14, 2026
Sponsor: National and Kapodistrian University of Athens
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Non-surgical peri-implant therapy

Implantoplasty

Prophylaxis

Clinical Study ID

NCT05899933
PERIO1
  • Ages 18-80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of the present study is to compare the 1-year clinical, radiographic and microbiological outcomes and patients' satisfaction following surgical treatment of peri-implantitis after applying two different surface modification methods. Secondarily, analysis and comparison of the microbiological results of implants diagnosed and treated for peri-implantitis with healthy implants will be performed.

Eligibility Criteria

Inclusion

Inclusion Criteria:

General Inclusion Criteria:

  • Participants ≥ 18 years and ≤ 80 years of age

  • Non-smokers based on the patients' self-reported smoking status, defined as patientswho had never smoked or had quit smoking at least 2 years ago

  • Implants in function for more than 1 year after suprastructure connection

Inclusion Criteria for implants diagnosed with Peri-Implantitis:

  • Presence of at least one implant diagnosed with peri-implantitis defined as presenceof bleeding on probing and/or suppuration, probing pocket depth ≥6 mm and ≥3 mm ofdetectable bone loss after initial re-modelling

  • Absence of implant mobility

  • in participants with more than one implant, the implant with the worst clinicalcondition will be studied.

Inclusion Criteria for implants diagnosed with Peri-Implant Health:

  • Absence of peri-implant signs of inflammation (redness, swelling)

  • Lack of bleeding on probing

  • Absence of bone loss beyond crestal bone level changes resulting from initialremodeling, which should not be ≥2 mm

Exclusion

Exclusion Criteria:

  • Smokers

  • Uncontrolled diabetes mellitus (HBA1c >7)

  • Treatment with bisphosphonates

  • Needing antibiotic prophylaxis

  • Currently pregnant or breast-feeding women

  • History of systemic administration of antibiotic treatment during the preceding 3months

  • Systemic conditions that contraindicate treatment

  • Use of medications known to induce gingival hyperplasia

Study Design

Total Participants: 45
Treatment Group(s): 4
Primary Treatment: Non-surgical peri-implant therapy
Phase:
Study Start date:
July 28, 2023
Estimated Completion Date:
December 31, 2026

Connect with a study center

  • Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens

    Athens, 11527
    Greece

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.